{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:22:54Z","timestamp":1790623374320,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:00:00Z","timestamp":1615334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:00:00Z","timestamp":1615334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2021,4,27]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Oral and gut microbiomes have emerged as potential biomarkers in cancer. We characterised the oral and gut microbiomes in a prospective observational cohort of HPV+ oropharyngeal squamous cell carcinoma (OPSCC) patients and evaluated the impact of chemoradiotherapy (CRT).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Saliva, oropharyngeal swabs over the tumour site and stool were collected at baseline and post-CRT. 16S RNA and shotgun metagenomic sequencing were used to generate taxonomic profiles, including relative abundance (RA), bacterial density, \u03b1-diversity and \u03b2-diversity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 132 samples from 22 patients were analysed. Baseline saliva and swabs had similar taxonomic composition (<jats:italic>R<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u20090.006; <jats:italic>p<\/jats:italic>\u2009=\u20090.827). Oropharyngeal swabs and stool taxonomic composition varied significantly by stage, with increased oral RA of <jats:italic>Fusobacterium nucleatum<\/jats:italic> observed in stage III disease (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). CRT significantly reduced the species richness and increased the RA of gut-associated taxa in oropharyngeal swabs (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05), while it had no effect in stool samples. These findings remained significant when adjusted by stage, smoking status and antibiotic use.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Baseline oral and gut microbiomes differ by stage in this HPV+ cohort. CRT caused a shift towards a gut-like microbiome composition in oropharyngeal swabs. Stage-specific features and the transitions in oral microbiome might have prognostic and therapeutic implications.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1038\/s41416-020-01253-1","type":"journal-article","created":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:13:34Z","timestamp":1615335214000},"page":"1543-1551","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Transitions in oral and gut microbiome of HPV+ oropharyngeal squamous cell carcinoma following definitive chemoradiotherapy (ROMA LA-OPSCC study)"],"prefix":"10.1038","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5352-8130","authenticated-orcid":false,"given":"Marc","family":"Oliva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8586-4937","authenticated-orcid":false,"given":"Pierre H. H.","family":"Schneeberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Rey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron R.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsty","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Hosni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Bayley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Hope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott V.","family":"Bratman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolie","family":"Ringash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simron","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Weinreb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bayardo","family":"Perez-Ordo\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Chepeha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Waldron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Guttman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3500-0540","authenticated-orcid":false,"given":"Lillian L.","family":"Siu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Coburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3034-3042","authenticated-orcid":false,"given":"Anna","family":"Spreafico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,10]]},"reference":[{"key":"1253_CR1","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1586\/14737140.2015.992785","volume":"15","author":"K Shahanavaj","year":"2015","unstructured":"Shahanavaj, K., Gil-Bazo, I., Castiglia, M., Bronte, G., Passiglia, F., Carreca, A. P. et al. Cancer and the microbiome: potential applications as new tumor biomarker. Expert Rev. Anticancer Ther. 15, 317\u2013330 (2015).","journal-title":"Expert Rev. Anticancer Ther."},{"key":"1253_CR2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/nrc.2017.13","volume":"17","author":"S Roy","year":"2017","unstructured":"Roy, S. & Trinchieri, G. Microbiota: a key orchestrator of cancer therapy. Nat. Rev. Cancer 17, 271\u2013285 (2017).","journal-title":"Nat. Rev. Cancer"},{"key":"1253_CR3","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1126\/science.aaa4972","volume":"348","author":"WS Garrett","year":"2015","unstructured":"Garrett, W. S. Cancer and the microbiota. Science 348, 80\u201386 (2015).","journal-title":"Science"},{"key":"1253_CR4","doi-asserted-by":"publisher","first-page":"368736","DOI":"10.1155\/2015\/368736","volume":"2015","author":"MH Nelson","year":"2015","unstructured":"Nelson, M. H., Diven, M. A., Huff, L. W. & Paulos, C. M. Harnessing the microbiome to enhance cancer immunotherapy. J. Immunol. Res. 2015, 368736 (2015).","journal-title":"J. Immunol. Res."},{"key":"1253_CR5","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/1471-2180-12-144","volume":"12","author":"S Pushalkar","year":"2012","unstructured":"Pushalkar, S., Ji, X., Li, Y., Estilo, C., Yegnanarayana, R., Singh, B. et al. Comparison of oral microbiota in tumor and non-tumor tissues of patients with oral squamous cell carcinoma. BMC Microbiol. 12, 144 (2012).","journal-title":"BMC Microbiol."},{"key":"1253_CR6","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1001\/jamaoncol.2017.4777","volume":"4","author":"RB Hayes","year":"2018","unstructured":"Hayes, R. B., Ahn, J., Fan, X., Peters, B. A., Ma, Y., Yang, L. et al. Association of oral microbiome with risk for incident head and neck squamous cell cancer. JAMA Oncol. 4, 358\u2013365 (2018).","journal-title":"JAMA Oncol."},{"key":"1253_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17795-z","volume":"7","author":"D Bornigen","year":"2017","unstructured":"Bornigen, D., Ren, B., Pickard, R., Li, J., Ozer, E., Hartmann, E. M. et al. Alterations in oral bacterial communities are associated with risk factors for oral and oropharyngeal cancer. Sci. Rep. 7, 17686 (2017).","journal-title":"Sci. Rep."},{"key":"1253_CR8","doi-asserted-by":"publisher","first-page":"51320","DOI":"10.18632\/oncotarget.9710","volume":"7","author":"R Guerrero-Preston","year":"2016","unstructured":"Guerrero-Preston, R., Godoy-Vitorino, F., Jedlicka, A., Rodr\u00edguez-Hilario, A., Gonz\u00e1lez, H., Bondy, J. et al. 16S rRNA amplicon sequencing identifies microbiota associated with oral cancer, human papilloma virus infection and surgical treatment. Oncotarget 7, 51320\u201351334 (2016).","journal-title":"Oncotarget"},{"key":"1253_CR9","doi-asserted-by":"publisher","first-page":"110931","DOI":"10.18632\/oncotarget.20677","volume":"8","author":"R Guerrero-Preston","year":"2017","unstructured":"Guerrero-Preston, R., White, J. R., Godoy-Vitorino, F., Rodriguez-Hilario, A., Navarro, K., Gonzalez, H. et al. High-resolution microbiome profiling uncovers Fusobacterium nucleatum, Lactobacillus gasseri\/johnsonii, and Lactobacillus vaginalis associated to oral and oropharyngeal cancer in saliva from HPV positive and HPV negative patients treated with surgery and chemo-radiation. Oncotarget 8, 110931\u2013110948 (2017).","journal-title":"Oncotarget"},{"key":"1253_CR10","doi-asserted-by":"publisher","first-page":"104453","DOI":"10.1016\/j.oraloncology.2019.104453","volume":"99","author":"E Orlandi","year":"2019","unstructured":"Orlandi, E., Iacovelli, N. A., Tombolini, V., Rancati, T., Polimeni, A., De Cecco, L. et al. Potential role of microbiome in oncogenesis, outcome prediction and therapeutic targeting for head and neck cancer. Oral Oncol. 99, 104453 (2019).","journal-title":"Oral Oncol."},{"key":"1253_CR11","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.oraloncology.2017.09.015","volume":"74","author":"N Osazuwa-Peters","year":"2017","unstructured":"Osazuwa-Peters, N., Simpson, M. C., Massa, S. T., Adjei Boakye, E., Antisdel, J. L. & Varvares, M. A. 40-year incidence trends for oropharyngeal squamous cell carcinoma in the United States. Oral Oncol. 74, 90\u201397 (2017).","journal-title":"Oral Oncol."},{"key":"1253_CR12","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1200\/JCO.2007.14.1713","volume":"26","author":"AK Chaturvedi","year":"2008","unstructured":"Chaturvedi, A. K., Engels, E. A., Anderson, W. F. & Gillison, M. L. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J. Clin. Oncol. 26, 612\u2013619 (2008).","journal-title":"J. Clin. Oncol."},{"key":"1253_CR13","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1093\/annonc\/mdx304","volume":"28","author":"M Taberna","year":"2017","unstructured":"Taberna, M., Mena, M., Pav\u00f3n, M. A., Alemany, L., Gillison, M. L. & Mes\u00eda, R. Human papillomavirus-related oropharyngeal cancer. Ann. Oncol. 28, 2386\u20132398 (2017).","journal-title":"Ann. Oncol."},{"key":"1253_CR14","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1200\/JCO.2012.44.0164","volume":"31","author":"B O\u2019Sullivan","year":"2013","unstructured":"O\u2019Sullivan, B., Huang, S. H., Siu, L. L., Waldron, J., Zhao, H., Perez-Ordonez, B. et al. Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis. J. Clin. Oncol. 31, 543\u2013550 (2013).","journal-title":"J. Clin. Oncol."},{"key":"1253_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.semradonc.2017.08.007","volume":"28","author":"SH Huang","year":"2018","unstructured":"Huang, S. H., O\u2019Sullivan, B. & Waldron, J. The current state of biological and clinical implications of human papillomavirus-related oropharyngeal cancer. Semin. Radiat. Oncol. 28, 17\u201326 (2018).","journal-title":"Semin. Radiat. Oncol."},{"key":"1253_CR16","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nmeth.f.303","volume":"7","author":"JG Caporaso","year":"2010","unstructured":"Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K. et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 7, 335\u2013336 (2010).","journal-title":"Nat. Methods"},{"key":"1253_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-019-0755-x","volume":"7","author":"PHH Schneeberger","year":"2019","unstructured":"Schneeberger, P. H. H., Prescod, J., Levy, L., Hwang, D., Martinu, T. & Coburn, B. Microbiota analysis optimization for human bronchoalveolar lavage fluid. Microbiome 7, 141 (2019).","journal-title":"Microbiome"},{"key":"1253_CR18","doi-asserted-by":"publisher","unstructured":"Edgar, R. C. UNOISE2: improved error-correction for Illumina 16S and ITS amplicon sequencing. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/081257 (2016).","DOI":"10.1101\/081257"},{"key":"1253_CR19","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/nmeth.2066","volume":"9","author":"N Segata","year":"2012","unstructured":"Segata, N., Waldron, L., Ballarini, A., Narasimhan, V., Jousson, O. & Huttenhower, C. Metagenomic microbial community profiling using unique clade-specific marker genes. Nat. Methods 9, 811\u2013814 (2012).","journal-title":"Nat. Methods"},{"key":"1253_CR20","doi-asserted-by":"publisher","first-page":"e61217","DOI":"10.1371\/journal.pone.0061217","volume":"8","author":"PJ McMurdie","year":"2013","unstructured":"McMurdie, P. J. & Holmes, S. phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS ONE 8, e61217 (2013).","journal-title":"PLoS ONE"},{"key":"1253_CR21","first-page":"631","volume":"10","author":"J Oksanen","year":"2007","unstructured":"Oksanen, J., Kindt, R., Legendre, P., O\u2019Hara, B., Stevens, M. H. H., Oksanen, M. J. et al. The vegan package. Community Ecol. Package 10, 631\u2013637 (2007).","journal-title":"Community Ecol. Package"},{"key":"1253_CR22","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing; 2015 (R Foundation for Statistical Computing, Vienna, 2018)."},{"key":"1253_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-017-0405-5","volume":"9","author":"H Wang","year":"2017","unstructured":"Wang, H., Funchain, P., Bebek, G., Altemus, J., Zhang, H., Niazi, F. et al. Microbiomic differences in tumor and paired-normal tissue in head and neck squamous cell carcinomas. Genome Med. 9, 14 (2017).","journal-title":"Genome Med."},{"key":"1253_CR24","doi-asserted-by":"publisher","first-page":"548.e16","DOI":"10.1016\/j.cell.2017.07.008","volume":"170","author":"T Yu","year":"2017","unstructured":"Yu, T., Guo, F., Yu, Y., Sun, T., Ma, D., Han, J. et al. Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy. Cell 170, 548.e16\u2013563.e16 (2017).","journal-title":"Cell"},{"key":"1253_CR25","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.3389\/fmicb.2019.01439","volume":"10","author":"Z Zhang","year":"2019","unstructured":"Zhang, Z., Yang, J., Feng, Q., Chen, B., Li, M., Liang, C. et al. Compositional and functional analysis of the microbiome in tissue and saliva of oral squamous cell carcinoma. Front. Microbiol. 10, 1439 (2019).","journal-title":"Front. Microbiol."},{"key":"1253_CR26","doi-asserted-by":"publisher","first-page":"6170","DOI":"10.1158\/1078-0432.CCR-19-0318","volume":"25","author":"K Yamamura","year":"2019","unstructured":"Yamamura, K., Izumi, D., Kandimalla, R., Sonohara, F., Baba, Y., Yoshida, N. et al. Intratumoral Fusobacterium nucleatum levels predict therapeutic response to neoadjuvant chemotherapy in esophageal squamous cell carcinoma. Clin. Cancer Res. 25, 6170\u20136179 (2019).","journal-title":"Clin. Cancer Res."},{"key":"1253_CR27","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ejca.2019.06.019","volume":"118","author":"M Oliva","year":"2019","unstructured":"Oliva, M., Huang, S. H., Xu, W., Su, J., Hansen, A. R., Bratman, S. V. et al. Impact of cisplatin dose and smoking pack-years in human papillomavirus-positive oropharyngeal squamous cell carcinoma treated with chemoradiotherapy. Eur. J. Cancer 118, 112\u2013120 (2019).","journal-title":"Eur. J. Cancer"},{"key":"1253_CR28","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1038\/ismej.2016.37","volume":"10","author":"J Wu","year":"2016","unstructured":"Wu, J., Peters, B. A., Dominianni, C., Zhang, Y., Pei, Z., Yang, L. et al. Cigarette smoking and the oral microbiome in a large study of American adults. ISME J. 10, 2435\u20132446 (2016).","journal-title":"ISME J."},{"key":"1253_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-016-0226-6","volume":"5","author":"G Yu","year":"2017","unstructured":"Yu, G., Phillips, S., Gail, M. H., Goedert, J. J., Humphrys, M. S., Ravel, J. et al. The effect of cigarette smoking on the oral and nasal microbiota. Microbiome 5, 3 (2017).","journal-title":"Microbiome"},{"key":"1253_CR30","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.oraloncology.2018.05.007","volume":"82","author":"H Mirghani","year":"2018","unstructured":"Mirghani, H., Leroy, C., Chekourry, Y., Casiraghi, O., Aup\u00e9rin, A., Tao, Y. et al. Smoking impact on HPV driven head and neck cancer\u2019s oncological outcomes? Oral Oncol. 82, 131\u2013137 (2018).","journal-title":"Oral Oncol."},{"key":"1253_CR31","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.oraloncology.2016.05.005","volume":"58","author":"JM Schuurhuis","year":"2016","unstructured":"Schuurhuis, J. M., Stokman, M. A., Witjes, M. J., Langendijk, J. A., van Winkelhoff, A. J., Vissink, A. et al. Head and neck intensity modulated radiation therapy leads to an increase of opportunistic oral pathogens. Oral Oncol. 58, 32\u201340 (2016).","journal-title":"Oral Oncol."},{"key":"1253_CR32","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.archoralbio.2013.10.011","volume":"59","author":"Y Xu","year":"2014","unstructured":"Xu, Y., Teng, F., Huang, S., Lin, Z., Yuan, X., Zeng, X. et al. Changes of saliva microbiota in nasopharyngeal carcinoma patients under chemoradiation therapy. Arch. Oral Biol. 59, 176\u2013186 (2014).","journal-title":"Arch. Oral Biol."},{"key":"1253_CR33","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/JLB.5HI1117-446RR","volume":"103","author":"A Perales-Puchalt","year":"2018","unstructured":"Perales-Puchalt, A., Perez-Sanz, J., Payne, K. K., Svoronos, N., Allegrezza, M. J., Chaurio, R. A. et al. Frontline Science: Microbiota reconstitution restores intestinal integrity after cisplatin therapy. J. Leukoc. Biol. 103, 799\u2013805 (2018).","journal-title":"J. Leukoc. Biol."},{"key":"1253_CR34","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ctrv.2017.07.003","volume":"59","author":"P Strojan","year":"2017","unstructured":"Strojan, P., Hutcheson, K. A., Eisbruch, A., Beitler, J. J., Langendijk, J. A., Lee, A. W. M. et al. Treatment of late sequelae after radiotherapy for head and neck cancer. Cancer Treat. Rev. 59, 79\u201392 (2017).","journal-title":"Cancer Treat. Rev."},{"key":"1253_CR35","doi-asserted-by":"publisher","unstructured":"Ferris, R. L., Blumenschein, G., Harrington, K., Fayette, J., Guigay, J., Colevas, A. D. et al. Evaluation of oral microbiome profiling as a response biomarker in squamous cell carcinoma of the head and neck: analyses from CheckMate 141. Cancer Res. https:\/\/doi.org\/10.1158\/1538-7445.AM2017-CT022 (2017).","DOI":"10.1158\/1538-7445.AM2017-CT022"},{"key":"1253_CR36","doi-asserted-by":"publisher","unstructured":"Hillmann, B., Al-Ghalith, G. A., Shields-Cutler, R. R., Zhu, Q., Gohl, D. M., Beckman, K. B. et al. Evaluating the information content of shallow shotgun metagenomics. mSystems https:\/\/doi.org\/10.1128\/mSystems.00069-18 (2018).","DOI":"10.1128\/mSystems.00069-18"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-020-01253-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-020-01253-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-020-01253-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T11:06:06Z","timestamp":1684753566000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-020-01253-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,10]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,4,27]]}},"alternative-id":["1253"],"URL":"https:\/\/doi.org\/10.1038\/s41416-020-01253-1","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,10]]},"assertion":[{"value":"31 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"ROMA LA-OPSCC-001 was a prospective observational study that only involved the collection and analysis of saliva, oropharyngeal swabs and stool samples and did not determine the eligibility to receive treatment. The study was approved by the Princess Margaret Cancer Centre Institutional Research Ethics Board (Study ID 17-5693) and was conducted in accordance with the Declaration of Helsinki. All patients provided written, signed, informed consent to participate.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The data sets generated and\/or analysed during the current study are not yet publicly available but are available from the corresponding author on reasonable request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"M.O.: consultant for: Bristol-Myers Squibb Canada (compensated), Mirati Therapeutics. Speaker\u2019s Bureau for: None. Employee of: None. Grant\/Research support from (Clinical Trials): Mirati Therapeutics, Nubyota. L.L.S.: Consultant for: Merck (compensated), Pfizer (compensated), Celgene (compensated), AstraZeneca\/Medimmune (compensated), Morphosys (compensated), Roche (compensated), GeneSeeq (compensated), Loxo (compensated), Oncorus (compensated), Symphogen (compensated), Seattle Genetics (compensated), GSK (compensated), Voronoi (compensated), Treadwell Therapeutics (compensated). Speaker\u2019s Bureau for: None. Grant\/Research support from (Clinical Trials for institution): Novartis, Bristol-Myers Squibb, Pfizer, Boerhinger-Ingelheim, GlaxoSmithKline, Roche\/Genentech, Karyopharm, AstraZeneca\/Medimmune, Merck, Celgene, Astellas, Bayer, Abbvie, Amgen, Symphogen, Intensity Therapeutics, Mirati, Shattucks, Avid. Stockholder in: Agios (spouse). Employee of: None. A.S.: consultant for: Merck (compensated), Bristol-Myers Squibb (compensated), Novartis (compensated), Oncorus (compensated). Speaker\u2019s Bureau for: None. Grant\/Research support from (Clinical Trials): Novartis, Bristol-Myers Squibb, Symphogen AstraZeneca\/Medimmune, Merck, Bayer, Surface Oncology, Northern Biologics, Janssen Oncology\/Johnson & Johnson, Roche, Array Biopharma. Stockholder in: None. Employee of: None. All of the other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was partly supported by M.O.\u2019s ASCO Conquer Cancer Foundation Young Investigator Award (YIA) 2019 and by A.S.\u2019s Division of Medical Oncology, Department of Medicine, University of Toronto Strategic Planning Innovation Grant. M.O.\u2019s fellowship program to conduct the ROMA LA-OPSCC study was supported by the Spanish Society for Medical Oncology Foundation (FSEOM)\/Fundaci\u00f3n Cris Contra el C\u00e1ncer Grant and by the Princess Margaret Cancer Centre Head & Neck Discovery Program. P.H.H.S. fellowship was partly supported by the Tomcyzk AI and Microbiome Working Group and The Princess Margaret Cancer Foundation.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding information"}}]}}